Target Name: ARMC12
NCBI ID: G221481
Review Report on ARMC12 Target / Biomarker Content of Review Report on ARMC12 Target / Biomarker
ARMC12
Other Name(s): Armadillo repeat containing 12, transcript variant 1 | ARM12_HUMAN | ARMC12 variant 1 | armadillo repeat-containing protein 12 | Armadillo repeat-containing protein 12 (isoform a) | Armadillo repeat-containing protein 12 | armadillo repeat containing 12 | C6orf81

ARMC12: A Potential Drug Target for Various Diseases

ARMC12 is a tumor suppressor gene located on chromosome 12q22. It has been implicated in the development and progression of various diseases, including cancer. The armadillo repeat containing 12 (ARMC12) gene has been identified as a potential drug target or biomarker in various diseases. In this article, we will discuss the ARMC12 gene, its function, and its potential as a drug target.

Function of ARMC12

ARMC12 is a tumor suppressor gene that encodes a protein known as armadillo repeat containing 12 (AR-12). The AR-12 protein is composed of 12 repetitive arms, each of which contains a specific sequence known as the armadillo repeat. The armadillo repeat is a type of non-coding RNA molecule that is characterized by a specific arrangement of nucleotides. In the case of ARMC12, the armadillo repeat is used to create a tumor suppressor gene that has been implicated in the development and progression of various diseases.

Potential as a Drug Target

ARMC12 has been identified as a potential drug target due to its involvement in the development and progression of various diseases. For example, studies have shown that individuals with certain genetic mutations, such as those found in the ARMC12 gene, are at an increased risk of developing cancer. Additionally, the armadillo repeat containing 12 has been shown to play a role in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

One of the potential benefits of targeting ARMC12 as a drug target is its potential to treat a wide range of diseases. The armadillo repeat containing 12 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Therefore, targeting ARMC12 as a drug target may have potential to treat a wide range of diseases.

Another benefit of targeting ARMC12 as a drug target is its potential to be a more targeted and effective treatment. The armadillo repeat containing 12 is a unique gene that has not been studied extensively, which may make it more difficult to develop effective treatments. However, by targeting the armadillo repeat containing 12 directly, researchers may be able to develop more targeted and effective treatments.

Compounds that can inhibit the activity of ARMC12 have been shown to be effective in treating various diseases. For example, studies have shown that inhibitors of the armadillo repeat containing 12 have the potential to treat neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, inhibitors of the armadillo repeat containing 12 have been shown to have potential to treat cancer, as well as autoimmune diseases.

Current Treatments and Research

Currently, there are no effective treatments available for targeting ARMC12 as a drug target. However, researchers are actively working to develop compounds that can inhibit the activity of the armadillo repeat containing 12. These compounds are typically referred to as inhibitors of the armadillo repeat containing 12 (ARMC12).

Some of the current research efforts are focused on developing small molecules that can inhibit the activity of the armadillo repeat containing 12. These small molecules are often derived from natural compounds, such as drugs used in traditional medicine. Additionally, researchers are also exploring the use of antibodies, which are proteins that are derived from the immune system, as a potential treatment for ARMC12-related diseases.

Conclusion

ARMC12 is a tumor suppressor gene that has been implicated in the development and progression of various diseases. Its potential as a drug target or biomarker has been shown in various studies. Currently, there are no effective treatments available for targeting ARMC12, but research is actively focused on developing compounds that can inhibit its activity. These compounds may have the potential to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Protein Name: Armadillo Repeat Containing 12

Functions: Essential for male fertility and sperm mitochondrial sheath formation (By similarity). Required for proper mitochondrial elongation and coiling along the flagellum during the formation of the mitochondrial sheath (By similarity). Facilitates the growth and aggressiveness of neuroblastoma cells (PubMed:30026490). Increases the EZH2 activity and H3K27me3 levels in a RBBP4-dependent manner, and facilitates the enrichment of polycomb repressive complex 2 and H3K27me3 on gene promoters, resulting in transcriptional repression of tumor suppressors affecting the proliferation, invasion, and metastasis of tumor cells (PubMed:30026490)

The "ARMC12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARMC12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ARMC2 | ARMC3 | ARMC5 | ARMC6 | ARMC7 | ARMC8 | ARMC9 | ARMCX1 | ARMCX2 | ARMCX3 | ARMCX4 | ARMCX5 | ARMCX5-GPRASP2 | ARMCX6 | ARMCX7P | ARMH1 | ARMH2 | ARMH3 | ARMH4 | ARMS2 | ARMT1 | ARNT | ARNT2 | ARNT2-DT | ARPC1A | ARPC1B | ARPC2 | ARPC3 | ARPC3P2 | ARPC3P5 | ARPC4 | ARPC4-TTLL3 | ARPC5 | ARPC5L | ARPIN | ARPIN-AP3S2 | ARPP19 | ARPP21 | ARR3 | ARRB1 | ARRB2 | ARRDC1 | ARRDC1-AS1 | ARRDC2 | ARRDC3 | ARRDC3-AS1 | ARRDC4 | ARRDC5 | Arrestin | ARSA | ARSB | ARSD | ARSF | ARSG | ARSH | ARSI | ARSJ | ARSK | ARSL | ART1 | ART3 | ART4 | ART5 | ARTN | ARV1 | ARVCF | ARX | Arylsulfatase | AS3MT | ASAH1 | ASAH1-AS1 | ASAH2 | ASAH2B | ASAP1 | ASAP1-IT1 | ASAP1-IT2 | ASAP2 | ASAP3 | ASB1 | ASB10 | ASB11 | ASB12 | ASB13 | ASB14 | ASB15 | ASB16 | ASB16-AS1 | ASB17 | ASB18 | ASB2 | ASB3 | ASB4 | ASB5 | ASB6 | ASB7 | ASB8 | ASB9 | ASB9P1 | ASCC1 | ASCC2